Drug research is also taking place at pace. Instead of preventing infection like vaccines, these are designed to boost the recovery of those who have been infected.
The WHO says it is getting daily proposals for potential medicine, yet many show no activity against the virus.
Two potential drugs are being tested at Medicins Sans Frontieres facilities.
They both interfere with the way viruses replicate inside our cells:
Brincidofovir - up to 140 consenting patients will take the tablets twice a week over a two-week period, and survival rates will be compared with before the trial. This research is led by the University of Oxford in the UK.
Favipiravir - is approved in Japan for treatment of the influenza virus and is being tested in Gueckedou, Guinea. The research is being led by the French National Institute of Health and Medical Research (Inserm).